The Irish Times

Allergan says it has been approached by another party

Actavis rumoured to be going head-to-head with rival Valeant for botox and eyecare group

Mon Nov 03 2014 - 18:32

Pharmaceutical firm’s offer values the Botox maker at $53bn

Tue Oct 28 2014 - 01:01

Canadian-based company said Allergan’s refusal to enter talks left it with no option but to go hostile

Wed Jun 11 2014 - 01:00

Scale of cuts savage despite a certain expectation of bad news

Fri May 30 2014 - 01:00

Disappointed Valeant expected to raise cash and stock offer to drive through merger of companies with significant overlap of shareholders

Mon May 12 2014 - 20:27

Pitching by bankers on tax inversion targets has reached fever pitch

Mon May 12 2014 - 01:05